In situ Polymerization of a PEG Monomer from the C-Terminus of an Intein Fusion Protein Significantly Improves Pharmacokinetics and Tumor Accumulation

Weiping Gao,Ashutosh Chilkoti

2011-01-01

What problem does this paper attempt to address?

In Situ Growth Of A Peg-Like Polymer From The C Terminus Of An Intein Fusion Protein Improves Pharmacokinetics And Tumor Accumulation

Weiping Gao,Wenge Liu,Trine Christensen,Michael R Zalutsky,Ashutosh Chilkoti

DOI: https://doi.org/10.1073/pnas.1006044107

2010-01-01

Abstract:This paper reports a general in situ method to grow a polymer conjugate solely from the C terminus of a recombinant protein. GFP was fused at its C terminus with an intein; cleavage of the intein provided a unique thioester moiety at the C terminus of GFP that was used to install an atom transfer radical polymerization (ATRP) initiator. Subsequent in situ ATRP of oligo(ethylene glycol) methyl ether methacrylate (OEGMA) yielded a site-specific (C-terminal) and stoichiometric conjugate with high yield and good retention of protein activity. A GFP-C-poly(OEGMA) conjugate (hydrodynamic radius (R(h)): 21 nm) showed a 15-fold increase in its blood exposure compared to the protein (R(h): 3.0 nm) after intravenous administration to mice. This conjugate also showed a 50-fold increase in tumor accumulation, 24 h after intravenous administration to tumor-bearing mice, compared to the unmodified protein. This approach for in situ C-terminal polymer modification of a recombinant protein is applicable to a large subset of recombinant protein and peptide drugs and provides a general methodology for improvement of their pharmacological profiles.
A Novel Zwitterionic Copolymer with A Short Poly(Methyl Acrylic Acid) Block for Improving Both Conjugation and Separation Efficiency of A Protein Without Losing Its Bioactivity

Weifeng Lin,Hui Zhang,Jiang Wu,Zhen Wang,Haotian Sun,Jiang Yuan,Shengfu Chen

DOI: https://doi.org/10.1039/c3tb00474k

IF: 7.571

2013-01-01

Journal of Materials Chemistry B

Abstract:PEGylation of protein drugs has thus far been the most important method used in improving the stability and the circulation time, while lowering the immunogenicity of protein drugs. However, the loss of bioactivity of PEGylated protein drugs and the low recovery through the complicated separation process are the most challenging issues. To overcome these problems, a zwitterionic block copolymer poly(methyl acrylic acid-b-sulfobetaine methacrylate) (PMAA-b-PSBMA or abbreviated to PMS) has been chosen to modify a protein drug (uricase) since zwitterionic materials are superior to polyethylene glycol (PEG) in resistance to nonspecific protein adsorption, chemical stability and also low cytotoxicity. As indicated by the results, the conjugation between PMS and uricase could be achieved under 0.03 mg mL-1 of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl) and 0.018 mg mL-1N-hydroxysuccinimide (NHS) through weak charge-induced adsorption of PMS on uricase, which is about 0.3% of the concentration for conventional protein-polymer conjugation. The conjugates, efficiently separated from the reaction solution and re-suspended in physiological solution through pH adjustment from pH 5.35 to 7.4, show about 133% of the original activity and better anti-trypsin digestion than the native uricase. These results demonstrate that the conjugation of a zwitterionic copolymer with a short poly(methyl acrylic acid) block could improve the stability of an enzyme without destructively affecting its bioactivity. This may open a new way for the delivery of therapeutic protein drugs.
A facile entrapment approach to construct PEGylated polyplexes for improving stability in physiological condition.

Youxiang Wang,Ping Chen,Jiacong Shen

DOI: https://doi.org/10.1016/j.colsurfb.2007.03.008

2007-01-01

Abstract:PEGylated polyplexes had been proved to improve the stability of DNA complexes. However, the conjugation reaction might reduce the capacity of efficient DNA complexation. Herein we described an easy and favorable approach to construct PEGylated polyplexes via entrapping poly(ethylene glycol) cholesterol ether (CPEG) into polyplexes. It was of interest to find the addition sequence of CPEG had great effect on the stability of polyplexes in physiological salt concentration. The addition of CPEG into the formed PEI25k/DNA polyplexes had no effect to improve the stability. Whereas by the “CPEG first” method of adding CPEG and PEI25k mixture into the DNA solution, the PEI25k/CPEG/DNA polyplexes showed excellent anti-aggregation effect and enhanced transfection efficiency in physiological condition. The difference performance might be explained by the possibility of CPEG entrapment. By the “CPEG first” method, PEGylated polyplexes was constructed due to the hydrophobic interaction between the cholesterol group of CPEG and hydrophobic charged-compensated core. The PEG coating significantly improved the stability of polyplexes in physiological condition. This facile entrapment approach to prepare PEGylated polyplexes might have great potential in non-viral gene delivery research and application.
In Situ Growth Of A Stoichiometric Peg-Like Conjugate At A Protein'S N-Terminus With Significantly Improved Pharmacokinetics

Weiping Gao,Wenge Liu,J. Andrew Mackay,Michael R. Zalutsky,Eric J. Toone,Ashutosh Chilkoti

DOI: https://doi.org/10.1073/pnas.0904378106

2009-01-01

Abstract:The challenge in the synthesis of protein-polymer conjugates for biological applications is to synthesize a stoichiometric (typically 1: 1) conjugate of the protein with a monodisperse polymer, with good retention of protein activity, significantly improved pharmacokinetics and increased bioavailability, and hence improved in vivo efficacy. Here we demonstrate, using myoglobin as an example, a general route to grow a PEG-like polymer, poly(oligo(ethylene glycol) methyl ether methacrylate) [poly(OEGMA)], with low polydispersity and high yield, solely from the N-terminus of the protein by in situ atom transfer radical polymerization (ATRP) under aqueous conditions, to yield a site-specific (N-terminal) and stoichiometric conjugate (1:1). Notably, the myoglobin-poly(OEGMA) conjugate [hydrodynamic radius (R-h): 13 nm] showed a 41-fold increase in its blood exposure compared to the protein (R-h: 1.7 nm) after IV administration to mice, thereby demonstrating that comb polymers that present short oligo(ethylene glycol) side chains are a class of PEG-like polymers that can significantly improve the pharmacological properties of proteins. We believe that this approach to the synthesis of N-terminal protein conjugates of poly(OEGMA) may be applicable to a large subset of protein and peptide drugs, and thereby provide a general methodology for improvement of their pharmacological profiles.
Site-specific in Situ Growth of an Interferon-Polymer Conjugate That Outperforms PEGASYS in Cancer Therapy.

Jin Hu,Guilin Wang,Wenguo Zhao,Weiping Gao

DOI: https://doi.org/10.1016/j.biomaterials.2016.04.035

IF: 14

2016-01-01

Biomaterials

Abstract:Conjugating therapeutic proteins and peptides to poly(ethylene glycol) (PEG) can improve their pharmacokinetics and therapeutic potential. However, PEGylation suffers from non-specific conjugation, low yield and immunogenicity. Herein we report a new and general methodology to synthesize a protein-polymer conjugate with site-specificity, high yield and activity, long circulation half-life and excellent therapeutic efficacy. A phospholipid polymer, poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC), was grown solely from the C-terminus of interferon-alpha to form a site-specific (C-terminal) and stoichiometric (1:1) PMPC conjugate of interferon-alpha in high yield. Notably, the PMPC conjugate showed 194- and 158-fold increases in systemic exposure and tumor uptake as compared with interferon-alpha, respectively. The in vitro antiproliferative bioactivity of the PMPC conjugate was 8.7-fold higher than that of PEGylated interferon-alpha (PEGASYS). In a murine cancer model, the PMPC conjugate completely inhibited tumor growth and cured 75% mice, whereas at the same dose, no mice treated with interferon-alpha or PEGASYS survived. We believe that this new approach to synthesize C-terminal protein conjugates of PMPC may be applicable to a large subset of protein and peptide drugs, thereby providing a general platform for the development of next-generation protein therapeutics.
Pyridine-2,6-dicarboxaldehyde-Enabled N-Terminal in Situ Growth of Polymer–Interferon Α Conjugates with Significantly Improved Pharmacokinetics and in Vivo Bioactivity

Jiawei Sun,Xinyu Liu,Jianwen Guo,Wenguo Zhao,Weiping Gao

DOI: https://doi.org/10.1021/acsami.0c15786

IF: 9.5

2020-01-01

ACS Applied Materials & Interfaces

Abstract:Polymer-protein conjugates are a class of biohybrids with unique properties that are highly useful in biomedicine ranging from protein therapeutics to biomedical imaging; however, it remains a considerable challenge to conjugate polymers to proteins in a site-specific, mild, and efficient way to form polymer- protein conjugates with uniform structures and properties and optimal functions. Herein we report pyridine-2,6-dicarboxaldehyde (PDA)-enabled N-terminal modification of proteins with polymerization initiators for in situ growth of poly(oligo(ethylene glycoOmethyl ether methacrylate) (POEGMA) conjugates uniquely at the N-termini of a range of natural and recombinant proteins in a mild and efficient fashion. The formed POEGMA-protein conjugates showed highly retained in vitro bioactivity as compared with free proteins. Notably, the in vitro bioactivity of a POEGMA-interferon alpha (IFN) conjugate synthesized by this new chemistry is 8.1-fold higher than that of PEGASYS that is a commercially available and Food and Drug Administration (FDA) approved PEGylated IFN. The circulation half-life of the conjugate is similar to that of PEGASYS but is 46.2 times longer than that of free IFN. Consequently, the conjugate exhibits considerably improved antiviral bioactivity over free IFN and even PEGASYS in a mouse model. These results indicate that the PDA-enabled N-terminal grafting-from method is applicable to a number of proteins whose active sites are far away from the N-terminus for the synthesis of N-terminal polymer-protein conjugates with high yield, well-retained activity, and considerably improved pharmacology for biomedical applications.
Non-covalent PEGylation of proteins mediated by site-specific in situ polymerization induced co-assembly

Fei Jiao,QInzhi Su,Xinyu Liu

DOI: https://doi.org/10.1039/d4py00260a

IF: 4.6

2024-04-26

Polymer Chemistry

Abstract:Herein we present a method tailored for non-covalent PEGylation of proteins, which is achieved by site-specific in situ polymerization induced co-assembly (SI-PICA) of proteins and polyethylene glycol (PEG). Significantly, this approach aptly preserves the bioactivity of therapeutic proteins while concurrently enhancing their pharmacokinetic properties.

polymer science
PEG- and PDMAEG-graft-modified branched PEI as novel gene vector: synthesis, characterization and gene transfection.

Yuting Wen,Shirong Pan,Xin Luo,Wei Zhang,Yuan Shen,Min Feng

DOI: https://doi.org/10.1163/092050609X12459295750316

2012-01-01

Abstract:The cytotoxicity of polyethylenimine (PEI) was a dominating obstacle to its application. Introduction of poly(ethylene glycol) (PEG) blocks to PEI is one of the strategies to alleviate the cytotoxocity of PEI. However, it is well known that the transfection efficiency of PEGylated PEI is decreased to some extent compared to the corresponding PEI. Thus, the aim of our study was to enhance the transfection efficiency of PEGylated PEI. A series of tri-block co-polymers, PEG-g-PEI-g-poly(dimethylaminoethyl L-glutamine) (PEG-g-PEI-g-PDMAEG), as novel vectors for gene therapy was synthesized and evaluated. PEG-g-PEI was first obtained by linking PEG and PEI using isophorone diisocyanate (IPDI) as coupling reagent. The anionic co-polymerization of gamma-benzyl-L-glutamate N-carboxyanhydride (BLG-NCA) using PEG-g-PEI as a macro-initiator was carried out, followed by aminolysis with 2-dimethylaminoethylamine to obtain the target water-soluble tri-block co-polymer. The structures of the polymers were confirmed by FT-IR and (1)H-NMR. The influence of the molecular weight of PEI and the length of the PDMAEG chain on the physicochemical properties and transfection activity of polymer/DNA was evaluated. All PEI derivates were revealed to compact plasmid DNA effectively to give polyplexes with suitable size (approx. 100 nm) and moderate zeta potentials (10-15 mV) at N/P ratios over 10. The PEG-g-PEI-g-PDMAEG tri-block co-polymers displayed particularly low cytotoxicity, even at high concentration, reflecting an improved safety profile compared to PEI 25k. Gene transfection efficiency of PEG-g-PEI-g-PDMAEG on HeLa in the presence and absence of serum was determined. Remarkably, the transfection activity of PEG-g-PEI (10k)-g-PDMAEG (PPP-4)/DNA polyplex formulations was nearly twofold higher than PEI 25k/DNA formulations in vitro, and the transfection efficiency was less affected by the presence of serum. These results indicated that the synthesized PEG-g-PEI-g-PDMAEG tri-block co-polymers are promising candidates as carriers for gene delivery. (C) Koninklijke Brill NV, Leiden, 2010
Polymerization Induced Self-Assembly of a Site-Specific Interferon Α-Block Copolymer Conjugate into Micelles with Remarkably Enhanced Pharmacology

Xinyu Liu,Mengmeng Sun,Jiawei Sun,Jin Hu,Zhuoran Wang,Jianwen Guo,Weiping Gao

DOI: https://doi.org/10.1021/jacs.8b06013

IF: 15

2018-01-01

Journal of the American Chemical Society

Abstract:Conjugating a hydrophilic and protein-resistant polymer to a protein is a widely used strategy to extend the in vivo half-life of the protein; however, the benefit of the half-life extension is usually limited by the bioactivity decrease. Herein we report a supramolecular self-assembly strategy of site-specific in situ polymerization induced self-assembly (SI-PISA) to address the dilemma. An amphiphilic block copolymer (POEGMA-PHPMA) was directly grown from the C-terminus of an important therapeutic protein interferon-α (IFN) to in situ form IFN-POEGMA-PHPMA conjugate micelles. Notably, the in vitro bioactivity of the micelles was 21.5-fold higher than that of the FDA-approved PEGylated interferon-α PEGASYS. Particularly, the in vivo half-life of the micelles (83.8 h) was 1.7- and 100-fold longer than those of PEGASYS (49.5 h) and IFN (0.8 h), respectively. In a tumor-bearing mouse model, the micelles completely suppressed tumor growth with 100% animal survival, whereas at the same dose, PEGASYS and IFN were much less effective. These findings suggest that SI-PISA is promising as a next-generation technology to remarkably enhance the pharmacological performance of therapeutic proteins with short circulation half-lives.
Stimuli-Responsive Sulfoxide Polymer–Protein Conjugates with Improved Pharmacokinetics and Tumor Delivery

Gayathri R. Ediriweera,Yixin Chang,Qiaoyun Wang,Yutong Gong,Dewan T. Akhter,Huiwen Pang,Felicity Y. Han,Chunying Chen,Andrew K. Whittaker,Changkui Fu

DOI: https://doi.org/10.1021/acs.chemmater.3c01566

IF: 10.508

2023-08-31

Chemistry of Materials

Abstract:A growing number of reports of poly(ethylene glycol) (PEG)-associated immunogenicity have prompted the development of alternative polymers for bioconjugation to assist in overcoming the poor in vivo pharmacokinetic profile of proteins. In this study, we demonstrate the development of transferrin (Tf) protein–polymer conjugates using a highly hydrophilic sulfoxide polymer (poly(2-(methylsulfinyl)ethyl acrylate) (PMSEA)) that has recently emerged as a promising class of low-fouling polymer. A cleavable thioketal linker between the protein and polymer enabled successful protein release when the conjugates were exposed to an environment rich in reactive oxygen species. Cleavage of the polymer circumvents the loss of protein activity upon chemical modification. The Tf-PMSEA conjugate was capable of significantly improving the in vivo pharmacokinetics of the protein and consequently enabled higher tumor accumulation of Tf-PMSEA in tumor-bearing mice compared to the PEGylated counterpart. This demonstrated the potential of PMSEA to be utilized in therapeutic delivery applications as a promising alternative to PEG.

materials science, multidisciplinary,chemistry, physical
Conjugation to increase treatment volume during local therapy: a case study with PEGylated camptothecin

Kraig Haverstick,Alison Fleming,W Mark Saltzman

DOI: https://doi.org/10.1021/bc700214h

Abstract:Controlled release of chemotherapy drugs from polymer implants placed directly at the tumor site is a proven method for treatment of cancers of the brain. Although this method provides high doses of drug at the tumor site, the drug does not penetrate far enough into the brain for optimum treatment in most cases. Rapid drug elimination leads to more than a 10-fold drop in concentration within 2 mm of the implant. Conjugation to water-soluble polymers, such as poly(ethylene glycol) (PEG) or dextran, has the potential to increase drug distribution in the brain. We have recently PEGylated the chemotherapy drug camptothecin and found a large increase in the extent of distribution of camptothecin in the rat brain, but most of the drug in tissue was in the less-active conjugated form. Stability of the conjugation bond, activity of the drug-polymer conjugate, solubility of the conjugate relative to the drug, and molecular weight of the polymer must all be considered in the design of a conjugate to maximize drug distribution. Therefore, to optimize the PEGylated system, we have developed a pharmacokinetic model to determine the relative importance of parameters involved in the distribution of drug-polymer conjugates after release from a polymer implant. Our modeling shows that PEGylation has the potential to increase treatment distances to more than a centimeter, which may be sufficient to prevent the recurrence of human brain tumors.
Circumvent PEGylation Dilemma by Implementing Matrix Metalloproteinase-Responsive Chemistry for Promoted Tumor Gene Therapy

Jingyun Wang,Hao Wang,Hongyan Cui,Peng Sun,Xi Yang,Qixian Chen

DOI: https://doi.org/10.1016/j.cclet.2020.07.027

IF: 9.1

2020-01-01

Chinese Chemical Letters

Abstract:Surface modification by poly(ethylene glycol) (PEGylation) has been acknowledged as a powerful strategy in minimizing non-specific reactions for biomedical devices. Once applied into manufacture of drug/gene delivery systems, PEGylation has demonstrated to significantly improve their biocompatibility and stealthiness in physiological environment. Nonetheless, reluctant cell membrane affinities thus cellular uptake efficiencies owing to PEGylation brought up further issues that are imperative to be resolved. Pertain to this PEGylation dilemma, we attempted to introduce peptide (GPLGVRG) linkage between block copolymer of PEG-poly{N'-[N-(2-aminoethyl)-2-aminoethyl]aspartamide} PAsp(DET), wherein the cationic PAsp(DET) could self-assemble with pDNA into nanoscaled complex core. Noteworthy was the peptide linkage whose amino acids sequence could be specifically recognized and degraded by matrix metalloproteinases (MMPs) (overexpressed in extracellular milieu of tumors). Therefore, our subsequent studies validated facile detachment of PEGylation from the aforementioned polyplex micelles upon treatment of MMPs, which elicited improved cytomembrane affinities and cellular uptake efficiencies. In addition, promoted escape from endosome entrapment was also confirmed through direct endosome membrane destabilization by PAsp(DET), which was further elucidated to be attributable to dePEGylation as well as elevated charged density of PAsp(DET) in acidic endosomes. These benefits from dePEGylation eventually contributed to promoted gene expression at the affected cells and potent tumor growth suppression based on anti-angiogenic approach. Therefore, our developed strategy has provided a facile approach in overcoming the dilemma of PEGylation, which could be informative in design of drug/gene delivery systems.
Synthesis and Characterization of Mpeg-Pcl-g-pei and Self-Assembled Nanoparticle Uptake in Vitro and in Vivo

Shuai Shi,Min Fan,Xiuhong Wang,Chengjian Zhao,Yingjing Wang,Feng Luo,Xia Zhao,Zhiyong Qian

DOI: https://doi.org/10.1021/jp108942b

2010-01-01

The Journal of Physical Chemistry C

Abstract:To understand in vitro and in vivo uptake of nanoparticle and enrichment is important for the improvement of therapeutic drug delivery. mPEG-PCL is a kind of biodegradable and biocompatible polymer suitable as a drug carrier, and many studies have been done to improve its bioavailability and loading capability. In this paper, a novel triblock mPEG-PCL-g-PEI polymer was synthesized and characterized. As compared with mPEG-PCL polymer, the developed copolymer also could self-assemble into nanoparticle with low zeta-potential at 50 degrees C. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay indicated that the obtained copolymer was low cytotoxicity in vitro. As labeled with FITC, in vitro cellular uptake of these nanoparticles was observed as a function with time. The in vivo fate of these nanoparticles was also observed in zebrafish model. On tumor-bearing mice, the nanoparticles were metabolized from kidney and were enriched in solid tumor in vivo. This study indicated that the triblock copolymer mPEG-PCL-g-PEI could be self-assembled into a nanoparticle with good biocompatibility suitable for a drug carrier.
Tumor-Targeted Accumulation of Ligand-Installed Polymeric Micelles Influenced by Surface PEGylation Crowdedness.

Xi Yang,Qixian Chen,Jinjun Yang,Sudong Wu,Jun Liu,Zhen Li,Deqiang Liu,Xiyi Chen,Yongming Qiu

DOI: https://doi.org/10.1021/acsami.7b16764

IF: 9.5

2017-01-01

ACS Applied Materials & Interfaces

Abstract:With respect to the intriguing biocompatibility and the stealthy functions of poly(ethylene glycol) (PEG), PEGylated nanoparticulates have been intensively engineered for utilities as drug delivery vehicles. To advocate the targeted drug transportation, targeting ligands were strategically installed onto the surface of PEGylated nanoparticulates. The previous in vitro investigations revealed that the ligand-specified cell endocytosis of nanoparticulates was pronounced for the nanoparticulates with adequately high PEG crowdedness. The present study aims to explore insight into the impact of PEGylation degree on in vivo tumor-targeted accumulation activities of cRGD-installed nanoparticulates. The subsequent investigations verified the importance of the PEGylation crowdedness in pursuit of prolonged retention in the blood circulation post intravenous administration. Unprecedentedly, the PEGylation crowdedness was also identified as a crucial important parameter to pursue the tumor-targeted accumulation. A plausible reason is the elevated PEGylation crowdedness eliciting the restricted involvement in nonspecific protein adsorption of nanoparticulates in the biological milieu and consequently pronouncing the ligand-receptor-mediated binding for the nanoparticulates. Noteworthy was the distinctive performance of the class of the proposed systems once utilized for transportation of the mRNA payload to the tumors. The protein expression in the targeted tumors appeared to follow a clear PEGylation crowdedness dependence manner, where merely 2-fold PEGylation crowdedness led to remarkably 10-fold augmentation in protein expression in tumors. Hence, the results provided important information and implications for design of active-targeting PEGylated nanomaterials to fulfill the targeting strategies in systemic applications.
Quantitatively fine-tuning the physicochemical and biological properties of peptidic polymers through monodisperse PEGylation.

Xuemeng Wang,Yu Li,Tingjuan Wu,Zhigang Yang,Xing Zheng,Shizhen Chen,Xin Zhou,Zhong-Xing Jiang

DOI: https://doi.org/10.1021/acs.biomac.9b01425

2020-01-01

Biomacromolecules

Abstract:In biomedicine, PEGylation is one of the most successful strategies to modify the physicochemical and biological properties of peptides, proteins, and other biomacromolecules. Because of the polydisperse nature of regular PEGs and limited PEGylation strategies, it is challenging to quantitatively fine-tune and accurately predict the properties of biomacromolecules after PEGylation. However, such fine-tuning and prediction may be crucial for their biomedical applications. Herein, some monodisperse PEGylation strategies, including backbone PEGylation, side-chain PEGylation, and highly branched PEGylation, have been developed. In a comparative fashion, the impact of PEGylation strategies and monodisperse PEG sizes on the physicochemical and biological properties, including lipophilicity, thermosensitivity, biocompatibility, plasma stability, and drug delivery capability, of peptidic polymers has been quantitatively studied. It was found that the physicochemical and biological properties of PEGylated peptidic polymers can be quantitatively fine-tuned and accurately predicted through these monodisperse PEGylation strategies. After the comparative study, a side-chain monodisperse PEGylated peptidic polymer was chosen as fluorine-19 magnetic resonance and fluorescence dual-imaging traceable drug delivery vehicle. Our study may not only promote the transformation of PEGylation from an empirical technology to a quantitative science but also shed light on the rational design of PEGylated biomaterials and pharmaceutics.
Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

Zeliang Zheng,Ryuhei Okada,Hisataka Kobayashi,Tadanobu Nagaya,Junxia Wei,Qi Zhou,Fred Lee,Tapan K Bera,Yun Gao,William Kuhlman,Chin-Hsien Tai,Ira Pastan,Tapan K. Bera

DOI: https://doi.org/10.1158/1535-7163.MCT-19-0890

2020-03-03

Molecular Cancer Therapeutics

Abstract:Recombinant immunotoxins (RIT) are chimeric proteins containing an Fv that binds to tumor cells, fused to a fragment of Pseudomonas exotoxin (PE) that kills the cell. Their efficacy is limited by their short half-life in the circulation. Chemical modification with polyethylene glycol (PEG) is a well-established method to extend the half-lives of biologics. Our goal was to engineer RITs with an increase in half-life and high cytotoxic activity. We introduced single cysteines at different locations in five anti-mesothelin RITs and employed site-specific PEGylation to conjugate them to 20-kDa PEG. Because our previous PEGylation method using β-mercaptoethanol reduction gave poor yields of PEG-modified protein, we employed a new method using tris(2-carboxyethyl)phosphine to reduce the protein and could PEGylate RITs at approximately 90% efficiency. The new proteins retained 19% to 65% of cytotoxic activity. Although all proteins are modified with the same PEG, the radius of hydration varies from 5.2 to 7.1, showing PEG location has a large effect on protein shape. The RIT with the smallest radius of hydration has the highest cytotoxic activity. The PEGylated RITs have a 10- to 30-fold increase in half-life that is related to the increase in hydrodynamic size. Biodistribution experiments indicate that the long half-life is due to delayed uptake by the kidney. Antitumor experiments show that several PEG-RITs are much more active than unmodified RIT, and the PEG location greatly affects antitumor activity. We conclude that PEGylation is a useful approach to improve the half-life and antitumor activity of RITs.

oncology
839. The Effect of PEGylation on Polyplexes Containing Ligands: Morphology and Binding Efficiency

Yan Guo,Jianren Gu,Yuhong Xu

DOI: https://doi.org/10.1016/j.ymthe.2004.06.740

IF: 12.91

2004-01-01

Molecular Therapy

Abstract:Cationic polymer/DNA complexes (polyplexes) are important non viral gene delivery vehicles. For target specific delivery by intravenous administration, formulations containing conjugated ligands and PEG are being developed. However, the influences of these modifications to the physical properties and binding capacities of the polyplexes were not so clear. In this paper, we combined the studies using photon correlation spectroscopy (PCS), atomic force microscope (AFM) and surface plasmon resonance (SPR) to elucidate the effects of PEG modifications.
Mixtures of Poly(triethylenetetramine/cystamine Bisacrylamide) and Poly(triethylenetetramine/cystamine Bisacrylamide)-G-poly(ethylene Glycol) for Improved Gene Delivery

Jonathan H. Brumbach,Chao Lin,James Yockman,Won Jong Kim,Katherine S. Blevins,Johan F. J. Engbersen,Jan Feijen,Sung Wan Kim

DOI: https://doi.org/10.1021/bc900522x

IF: 4.7

2010-01-01

Bioconjugate Chemistry

Abstract:Branched disulfide-containing poly(amido ethyleneimines) (SS-PAEIs) are biodegradable polymeric gene carrier analogues of the well-studied, nondegradable, and often toxic branched polyethylenimines (bPEIs), but with distinct advantages for cellular transgene delivery. Clinical success of polycationic gene carriers is hampered by obscure design and formulation requirements. This present work reports synthetic and formulation properties for a graft copolymer of poly(ethylene glycol) (PEG) and a branched SS-PAEI, poly(triethylentetramine/cystaminebisacrylamide) (p(TETA/CBA)). Several laboratories have previously demonstrated the advantages of PEG conjugation to gene carriers, but have also shown that PEG conjugation may perturb plasmid DNA (pDNA) condensation, thereby interfering with nanoparticle formation. With this foundation, our studies sought to mix various amounts of p(TETA/CBA) and p(TETA/CBA)-g-PEG2k to alter the relative amount of PEG in each formulation used for polyplex formation. The influence of different PEG/polycation amounts in the formulations on polymer/nucleic acid nanoparticle (polyplex) size, surface charge, morphology, serum stability and transgene delivery was studied. Polyplex formulations were prepared using p(TETA/CBA)-g-PEG2k, p(TETA/CBA), and mixtures of the two species at 10/90 and 50/50 volumetric mixture ratios (wt/wt %), respectively. As expected, increasing the amount of PEG in the formulation adversely affects polyplex formation. However, optimal polymer mixtures could be identified using this facile approach to further clarify design and formulation requirements necessary to understand and optimize carrier stability and biological activity. This work demonstrates the feasibility to easily overcome typical problems observed when polycations are modified and thus avoids the need to synthesize multiple copolymers to identify optimal gene carrier candidates. This approach may be applied to other polycation-PEG preparations to alter polyplex characteristics for optimal stability and biological activity.
Synthesis and gene transfection efficiency of PEG-chitosan-PEI copolymers

Wei Zhang,Shirong Pan,Yuting Wen,Xin Luo

DOI: https://doi.org/10.1007/978-3-540-79039-6_3

2008-01-01

Abstract:PEG-chitosan-PEI copolymer was synthesized by ring-opening reaction of ethylenimine monomers with PEG-chitosan. PEG-chitosan was prepared before by an imine reaction between chitosan and mPEG-CHO. With the aim to investigate the gene transfection properties of PEG-chitosan-PEI, we investigated its cytotoxicity by MITT assay, DNA compaction ability by agarose gel retardation, and transfection efficiency of pEGFP in vitro. The results showed higher transfection efficiency and lower cytotoxicity of PEG-chitosan-PEI than PEI(25k) which is a popular gene vector.
Polyplex Micelle with Ph-Responsive PEG Detachment and Functional Tetraphenylene Incorporation to Promote Systemic Gene Expression

Zhu Jiang,Qixian Chen,Xi Yang,Xiyi Chen,Zhen Li,De-E Liu,Wei Li,Yingjie Lei,Hui Gao

DOI: https://doi.org/10.1021/acs.bioconjchem.7b00557

IF: 4.7

2017-01-01

Bioconjugate Chemistry

Abstract:Tetraphenylene (TPE), characterized as a lipophilic and aggregation-induced-emissive fluorophore, was used to incorporate into an electrostatic self-assembled polyethylenimine-poly(ethylene glycol) (PEI-PEG)/plasmid DNA (pDNA) complexed micelle. The hydrophobic character of TPE appeared to drive a higher degree of condensation of the pDNA payload, which consequently resulted in not only strengthened colloidal stability of the constructed polyplex micelle but also improved biocompatibility by virtue of the elevated PEG crowdedness owing to the TPE-induced collapse of pDNA. These beneficial consequences potentially permitted a larger number of polyplex micelles to be internalized into the cells. PEG segments were designed to enable selective detachment from polyplex micelles in acidic milieu, e.g., the tumor microenvironment, and intracellular endosome compartment, based on the strategic arrangement of acid-responsive cleavable linkage between PEG and PEI. Upon PEG detachment, the exposure of cationic PEI/TPE polyplex was allowed to directly interact with the cell membrane, endosome membrane, and charged intracellular species, thus promoting cell internalization, endosome escape, and the release of the pDNA payload. Of note, this association of cationic PEI/TPE polyplex with the endosomal membrane could be further facilitated with the aid of lipophilic TPE, thereby eliciting pronounced destabilization potency to the endosome membrane and exerting an endosomal escape function. Eventually, the proposed system of these facile strategies, including responsive PEG detachment and functional TPE incorporation, was proven to provide efficient gene expression in the targeted tumors with an appreciable safety profile via systemic administration.

In situ Polymerization of a PEG Monomer from the C-Terminus of an Intein Fusion Protein Significantly Improves Pharmacokinetics and Tumor Accumulation

In Situ Growth Of A Peg-Like Polymer From The C Terminus Of An Intein Fusion Protein Improves Pharmacokinetics And Tumor Accumulation

A Novel Zwitterionic Copolymer with A Short Poly(Methyl Acrylic Acid) Block for Improving Both Conjugation and Separation Efficiency of A Protein Without Losing Its Bioactivity

A facile entrapment approach to construct PEGylated polyplexes for improving stability in physiological condition.

In Situ Growth Of A Stoichiometric Peg-Like Conjugate At A Protein'S N-Terminus With Significantly Improved Pharmacokinetics

Site-specific in Situ Growth of an Interferon-Polymer Conjugate That Outperforms PEGASYS in Cancer Therapy.

Pyridine-2,6-dicarboxaldehyde-Enabled N-Terminal in Situ Growth of Polymer–Interferon Α Conjugates with Significantly Improved Pharmacokinetics and in Vivo Bioactivity

Non-covalent PEGylation of proteins mediated by site-specific in situ polymerization induced co-assembly

PEG- and PDMAEG-graft-modified branched PEI as novel gene vector: synthesis, characterization and gene transfection.

Polymerization Induced Self-Assembly of a Site-Specific Interferon Α-Block Copolymer Conjugate into Micelles with Remarkably Enhanced Pharmacology

Stimuli-Responsive Sulfoxide Polymer–Protein Conjugates with Improved Pharmacokinetics and Tumor Delivery

Conjugation to increase treatment volume during local therapy: a case study with PEGylated camptothecin

Circumvent PEGylation Dilemma by Implementing Matrix Metalloproteinase-Responsive Chemistry for Promoted Tumor Gene Therapy

Synthesis and Characterization of Mpeg-Pcl-g-pei and Self-Assembled Nanoparticle Uptake in Vitro and in Vivo

Tumor-Targeted Accumulation of Ligand-Installed Polymeric Micelles Influenced by Surface PEGylation Crowdedness.

Quantitatively fine-tuning the physicochemical and biological properties of peptidic polymers through monodisperse PEGylation.

Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

839. The Effect of PEGylation on Polyplexes Containing Ligands: Morphology and Binding Efficiency

Mixtures of Poly(triethylenetetramine/cystamine Bisacrylamide) and Poly(triethylenetetramine/cystamine Bisacrylamide)-G-poly(ethylene Glycol) for Improved Gene Delivery

Synthesis and gene transfection efficiency of PEG-chitosan-PEI copolymers

Polyplex Micelle with Ph-Responsive PEG Detachment and Functional Tetraphenylene Incorporation to Promote Systemic Gene Expression